Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a single patient compassionate use protocol to determine whether RAVICTI will improve
bile flow in a subject who previously tolerated therapy with Buphenyl.